3FII
Crystal structure of Clostridium botulinum neurotoxin serotype F catalytic domain with an inhibitor (inh2)
Functional Information from GO Data
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 9 |
| Details | BINDING SITE FOR RESIDUE 00C B 58 |
| Chain | Residue |
| A | GLU164 |
| A | ASN165 |
| A | SER166 |
| A | HIS227 |
| A | GLU228 |
| A | GLU266 |
| A | TYR368 |
| A | ZN822 |
| B | ASP57 |
| site_id | AC2 |
| Number of Residues | 4 |
| Details | BINDING SITE FOR RESIDUE ZN A 822 |
| Chain | Residue |
| A | HIS227 |
| A | HIS231 |
| A | GLU266 |
| B | 00C58 |
Functional Information from PROSITE/UniProt
| site_id | PS00142 |
| Number of Residues | 10 |
| Details | ZINC_PROTEASE Neutral zinc metallopeptidases, zinc-binding region signature. SLAHELIHAL |
| Chain | Residue | Details |
| A | SER224-LEU233 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 1 |
| Details | Active site: {"evidences":[{"source":"PROSITE-ProRule","id":"PRU10095","evidenceCode":"ECO:0000255"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 2 |
| Details | Binding site: {"evidences":[{"source":"PROSITE-ProRule","id":"PRU10095","evidenceCode":"ECO:0000255"},{"source":"PubMed","id":"19543288","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"3FIE","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3FII","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 1 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"19543288","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"3FIE","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3FII","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
Catalytic Information from CSA
| site_id | CSA1 |
| Number of Residues | 3 |
| Details | Annotated By Reference To The Literature 1i1e |
| Chain | Residue | Details |
| A | TYR368 | |
| A | GLU266 | |
| A | ARG365 |






